FIELD: medicine; transfusiology; surgery; oncology.
SUBSTANCE: invention can be used for preoperative correction of anemia in patients with colorectal cancer with liver metastases. The method includes the administration of Darbopoietin alfa and an iron agent. Darbopoetin alfa is administered 21 days before surgery once subcutaneously in an amount of 6.75 mcg/kg, iron (III) hydroxide oligoisomaltose as an iron agent is administered in an amount of 20 mg/kg once intravenously 21 days before surgery. Additionally, 21 days before surgery, oral administration of the anticoagulant Rivaroxaban 10 mg daily for 16 days is prescribed, after which daily subcutaneous administration of low molecular weight heparin — Enoxaparin Sodium 40 mg-4000 anti Xa ME — is performed for five days.
EFFECT: invention makes it possible to stimulate erythropoiesis in the preoperative period in patients with colorectal cancer with metastatic liver disease and minimizes the risk of thromboembolic complications.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTING ANEMIA IN PREOPERATIVE PERIOD IN PATIENTS WITH GASTRIC CANCER | 2020 |
|
RU2759044C1 |
METHOD OF INFUSION MEDICATION OF SPINAL SURGERY IN CHILDREN | 2008 |
|
RU2387452C1 |
METHOD OF TREATING LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER | 2013 |
|
RU2528881C1 |
METHOD FOR PREDICTION OF EXERCISE TOLERANCE IN PATIENTS WITH STABLE ANGINA PECTORIS COMBINED WITH IRON DEFICIENCY ANAEMIA | 2024 |
|
RU2826095C1 |
METHOD FOR RECONSTRUCTION OF ORAL CAVITY DEFECTS IN CASE OF ORAL MUCOSA AND SUBMANDIBULAR CANCER MUCOSA | 2018 |
|
RU2706031C1 |
METHOD OF TREATING LOCAL RECURRENCE OF PANCREATIC CANCER FOLLOWING RADICAL SURGERY | 2013 |
|
RU2526802C1 |
METHOD OF AUTOBLOOD PREOPERATIVE PREPARATION | 2006 |
|
RU2328315C1 |
METHOD FOR PREVENTING AND CORRECTING ANEMIA STATE IN METASTATIC MAMMARY GLAND CARCINOMA PATIENTS | 2005 |
|
RU2314122C2 |
METHOD FOR CORRECTION OF ANEMIA IN ERYTHROCYTES TRANSFUSION DEPENDENT PATIENTS WITH BETA-THALASSEMIA | 2023 |
|
RU2820878C1 |
METHOD FOR COMBINED TREATMENT FOR ASIDEROTIC ANEMIA | 2007 |
|
RU2331412C1 |
Authors
Dates
2024-01-19—Published
2023-05-29—Filed